Valeo Financial Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-687
Closed -$149K 2100
2021
Q1
$149K Sell
687
-25
-4% -$4.7K 0.01% 513
2020
Q4
$82K Sell
712
-50
-7% -$5.6K ﹤0.01% 625
2020
Q3
$74K Sell
762
-135
-15% -$15.5K 0.01% 545
2020
Q2
$110K Buy
897
+135
+18% +$15.3K 0.01% 485
2020
Q1
$72K Buy
762
+300
+65% +$31.8K 0.01% 503
2019
Q4
$48K Buy
462
+200
+76% +$22.4K ﹤0.01% 669
2019
Q3
$30K Buy
262
+200
+323% +$30.4K ﹤0.01% 749
2019
Q2
$11K Sell
62
-200
-76% -$34.6K ﹤0.01% 1011
2019
Q1
$44K Hold
262
0.01% 597
2018
Q4
$26K Hold
262
﹤0.01% 640
2018
Q3
$36K Buy
262
+237
+948% +$34.2K ﹤0.01% 620
2018
Q2
$3K Buy
+25
New +$3.55K ﹤0.01% 1299

Other funds holding GWPH

Valeo Financial Advisors's GWPH Position: Q2 2021 in Review

Valeo Financial Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 687 shares — an estimated $149K sold.

Valeo Financial Advisors first reported a position in GWPH in Q2 2018 and held it in 12 quarters. The position peaked at $149K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Valeo Financial Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 687 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $149K.
  • Valeo Financial Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 12 quarters.
  • Valeo Financial Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $149K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.